<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37484765</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-2360</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in pediatrics</Title><ISOAbbreviation>Front Pediatr</ISOAbbreviation></Journal><ArticleTitle><i>Streptococcus pneumoniae</i> nasal carriage patterns with and without common respiratory virus detections in households in Seattle, WA, USA before and during the COVID-19 pandemic.</ArticleTitle><Pagination><StartPage>1198278</StartPage><MedlinePgn>1198278</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1198278</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fped.2023.1198278</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Respiratory viruses might influence <i>Streptococcus pneumoniae</i> nasal carriage and subsequent disease risk. We estimated the association between common respiratory viruses and semiquantitative <i>S. pneumoniae</i> nasal carriage density in a household setting before and during the COVID-19 pandemic.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">From November 2019-June 2021, we enrolled participants in a remote household surveillance study of respiratory pathogens. Participants submitted weekly reports of acute respiratory illness (ARI) symptoms. Mid-turbinate or anterior nasal swabs were self-collected at enrollment, when ARI occurred, and, in the second year of the study only, from household contacts after SARS-CoV-2 was detected in a household member. Specimens were tested using multiplex reverse-transcription PCR for respiratory pathogens, including <i>S. pneumoniae</i>, rhinovirus, adenovirus, common human coronavirus, influenza A/B virus, respiratory syncytial virus (RSV) A/B, human metapneumovirus, enterovirus, and human parainfluenza virus. We estimated differences in semiquantitative <i>S. pneumoniae</i> nasal carriage density, estimated by the inverse of <i>S. pneumoniae</i> relative cycle threshold (Crt) values, with and without viral detection for any virus and for specific respiratory viruses using linear generalized estimating equations of <i>S. pneumoniae</i> Crt values on virus detection adjusted for age and swab type and accounting for clustering of swabs within households.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We collected 346 swabs from 239 individuals in 151 households that tested positive for <i>S. pneumoniae</i> (<i>n</i> = 157 with and 189 without ≥1 viruses co-detected). Difficulty breathing, cough, and runny nose were more commonly reported among individuals with specimens with viral co-detection compared to without (15%, 80% and 93% vs. 8%, 57%, and 51%, respectively) and ear pain and headache were less commonly reported (3% and 26% vs. 16% and 41%, respectively). For specific viruses among all ages, semiquantitative <i>S. pneumoniae</i> nasal carriage density was greater with viral co-detection for enterovirus, RSV A/B, adenovirus, rhinovirus, and common human coronavirus (<i>P</i> &lt; 0.01 for each). When stratified by age, semiquantitative <i>S. pneumoniae</i> nasal carriage density was significantly greater with viral co-detection among children aged &lt;5 (<i>P</i> = 0.002) and 5-17 years (<i>P</i> = 0.005), but not among adults aged 18-64 years (<i>P</i> = 0.29).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Detection of common respiratory viruses was associated with greater concurrent <i>S. pneumoniae</i> semiquantitative nasal carriage density in a household setting among children, but not adults.</AbstractText><CopyrightInformation>© 2023 Bennett, Emanuels, Heimonen, O'Hanlon, Hughes, Han, Chow, Ogokeh, Rolfes, Lockwood, Pfau, Uyeki, Shendure, Hoag, Fay, Lee, Sibley, Rogers, Starita, Englund and Chu.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Julia C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Emanuels</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heimonen</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Hanlon</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>James P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Peter D</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Brotman Baty Institute for Precision Medicine, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Military and Health Research Foundation, Laurel, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Eric J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Communicable Disease Epidemiology and Immunizations Section, Prevention Division, Public Health - Seattle &amp; King County, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogokeh</LastName><ForeName>Constance E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Military and Health Research Foundation, Laurel, MD, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rolfes</LastName><ForeName>Melissa A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lockwood</LastName><ForeName>Christine M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Brotman Baty Institute for Precision Medicine, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfau</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Brotman Baty Institute for Precision Medicine, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genome Sciences, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uyeki</LastName><ForeName>Timothy M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shendure</LastName><ForeName>Jay</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Brotman Baty Institute for Precision Medicine, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genome Sciences, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoag</LastName><ForeName>Samara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Student Health Services, Seattle Public Schools, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fay</LastName><ForeName>Kairsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jover</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sibley</LastName><ForeName>Thomas R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogers</LastName><ForeName>Julia H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Starita</LastName><ForeName>Lea M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Brotman Baty Institute for Precision Medicine, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genome Sciences, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Englund</LastName><ForeName>Janet A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Seattle Children's Research Institute, Department of Pediatrics, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Helen Y</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Washington, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pediatr</MedlineTA><NlmUniqueID>101615492</NlmUniqueID><ISSNLinking>2296-2360</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword><Keyword MajorTopicYN="N">nasal carriage</Keyword><Keyword MajorTopicYN="N">pneumococcal</Keyword><Keyword MajorTopicYN="N">respiratory</Keyword><Keyword MajorTopicYN="N">streptococcus pneumoniae</Keyword><Keyword MajorTopicYN="N">viruses</Keyword></KeywordList><CoiStatement>HC reports consulting with Ellume, Merck, Abbvie, Pfizer, The Bill and Melinda Gates Foundation. She has received research funding from Sanofi Pasteur, and support and reagents from Ellume and Cepheid outside of the submitted work. JE reports consulting with Ark Biopharmaceuticals, Sanofi Pasteur, Moderna, Meissa Vaccines, Astra Zeneca, and Pfizer, Inc. outside of the submitted work, and has received research funding from AstraZeneca, GlaxoSmithKline, and Pfizer. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>4</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37484765</ArticleId><ArticleId IdType="pmc">PMC10361771</ArticleId><ArticleId IdType="doi">10.3389/fped.2023.1198278</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wahl B, O’Brien KL, Greenbaum A, Majumder A, Liu L, Chu Y, et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15. Lancet Glob Health. (2018) 6(7):e744–57. 10.1016/S2214-109X(18)30247-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(18)30247-X</ArticleId><ArticleId IdType="pmc">PMC6005122</ArticleId><ArticleId IdType="pubmed">29903376</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Pneumococcal Disease. Available at: https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccine-standardization/pneumococcal-disease
(Accessed 12 Sep 2022).</Citation></Reference><Reference><Citation>Simell B, Auranen K, Käyhty H, Goldblatt D, Dagan R, O’Brien KL. The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines. (2012) 11(7):841–55. 10.1586/erv.12.53</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/erv.12.53</ArticleId><ArticleId IdType="pubmed">22913260</ArticleId></ArticleIdList></Reference><Reference><Citation>McCullers JA, McAuley JL, Browall S, Iverson AR, Boyd KL, Normark BH. Influenza enhances susceptibility to natural acquisition and disease from streptococcus pneumoniae in ferrets. J Infect Dis. (2010) 202(8):1287–95. 10.1086/656333</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/656333</ArticleId><ArticleId IdType="pmc">PMC3249639</ArticleId><ArticleId IdType="pubmed">20822454</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura S, Davis KM, Weiser JN. Synergistic stimulation of type I interferons during influenza virus coinfection promotes streptococcus pneumoniae colonization in mice. J Clin Invest. (2011) 121(9):3657–65. 10.1172/JCI57762</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI57762</ArticleId><ArticleId IdType="pmc">PMC3163966</ArticleId><ArticleId IdType="pubmed">21841308</ArticleId></ArticleIdList></Reference><Reference><Citation>Diavatopoulos DA, Short KR, Price JT, Wilksch JJ, Brown LE, Briles DE, et al. Influenza A virus facilitates streptococcus pneumoniae transmission and disease. FASEB J. (2010) 24(6):1789–98. 10.1096/fj.09-146779</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.09-146779</ArticleId><ArticleId IdType="pubmed">20097876</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha S, Foxman B, Weinberger DM, Steiner C, Viboud C, Rohani P. Identifying the interaction between influenza and pneumococcal pneumonia using incidence data. Sci Transl Med. (2013) 5(191):191ra84. 10.1126/scitranslmed.3005982</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3005982</ArticleId><ArticleId IdType="pmc">PMC4178309</ArticleId><ArticleId IdType="pubmed">23803706</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleming-Dutra KE, Taylor T, Link-Gelles R, Garg S, Jhung MA, Finelli L, et al. Effect of the 2009 influenza A(H1N1) pandemic on invasive pneumococcal pneumonia. J Infect Dis. (2013) 207(7):1135–43. 10.1093/infdis/jit008</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jit008</ArticleId><ArticleId IdType="pubmed">23303809</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberger DM, Simonsen L, Jordan R, Steiner C, Miller M, Viboud C. Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United States. J Infect Dis. (2012) 205(3):458–65. 10.1093/infdis/jir749</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jir749</ArticleId><ArticleId IdType="pmc">PMC3276240</ArticleId><ArticleId IdType="pubmed">22158564</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiavenna C, Presanis AM, Charlett A, de Lusignan S, Ladhani S, Pebody RG, et al. Estimating age-stratified influenza-associated invasive pneumococcal disease in England: a time-series model based on population surveillance data. PLoS Med. (2019) 16(6):e1002829. 10.1371/journal.pmed.1002829</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002829</ArticleId><ArticleId IdType="pmc">PMC6597037</ArticleId><ArticleId IdType="pubmed">31246954</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicoli EJ, Trotter CL, Turner KME, Colijn C, Waight P, Miller E. Influenza and RSV make a modest contribution to invasive pneumococcal disease incidence in the UK. J Infect. (2013) 66(6):512–20. 10.1016/j.jinf.2013.02.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2013.02.007</ArticleId><ArticleId IdType="pmc">PMC3650581</ArticleId><ArticleId IdType="pubmed">23473714</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciruela P, Broner S, Izquierdo C, Hernández S, Muñoz-Almagro C, Pallarés R, et al. Invasive pneumococcal disease rates linked to meteorological factors and respiratory virus circulation (catalonia, 2006–2012). BMC Public Health. (2016) 16:400. 10.1186/s12889-016-3061-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-016-3061-6</ArticleId><ArticleId IdType="pmc">PMC4866022</ArticleId><ArticleId IdType="pubmed">27178436</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter ND, Taylor TH, Shay DK, Thompson WW, Brammer L, Dowell SF, et al. Influenza circulation and the burden of invasive pneumococcal pneumonia during a non-pandemic period in the United States. Clin Infect Dis. (2010) 50(2):175–83. 10.1086/649208</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/649208</ArticleId><ArticleId IdType="pubmed">20014948</ArticleId></ArticleIdList></Reference><Reference><Citation>Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. (2008) 198(7):962–70. 10.1086/591708</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/591708</ArticleId><ArticleId IdType="pmc">PMC2599911</ArticleId><ArticleId IdType="pubmed">18710327</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Edwards KM, et al. Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. Am J Med. (2005) 118(3):285–91. 10.1016/j.amjmed.2004.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2004.09.016</ArticleId><ArticleId IdType="pubmed">15745727</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson GE, Gershman KA, Swerdlow DL, Beall BW, Moore MR. Invasive pneumococcal disease and pandemic (H1N1) 2009, Denver, Colorado, USA. Emerg Infect Dis. (2012) 18(2):208–16. 10.3201/eid1802.110714</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1802.110714</ArticleId><ArticleId IdType="pmc">PMC3310448</ArticleId><ArticleId IdType="pubmed">22306234</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen AG, Sanders EA, van der Ende A, van Loon AM, Hoes AW, Hak E. Invasive pneumococcal and meningococcal disease: association with influenza virus and respiratory syncytial virus activity? Epidemiol Infect. (2008) 136(11):1448–54. 10.1017/S0950268807000271</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268807000271</ArticleId><ArticleId IdType="pmc">PMC2870742</ArticleId><ArticleId IdType="pubmed">18211724</ArticleId></ArticleIdList></Reference><Reference><Citation>Ampofo K, Bender J, Sheng X, Korgenski K, Daly J, Pavia AT, et al. Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics. (2008) 122(2):229–37. 10.1542/peds.2007-3192</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2007-3192</ArticleId><ArticleId IdType="pubmed">18676537</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Haber M, Ray S, Farley MM, Panozzo CA, Klugman KP. Invasive pneumococcal pneumonia and respiratory virus co-infections. Emerg Infect Dis. (2012) 18(2):294–7. 10.3201/eid1802.102025</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1802.102025</ArticleId><ArticleId IdType="pmc">PMC3310442</ArticleId><ArticleId IdType="pubmed">22305270</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdoch DR, Jennings LC. Association of respiratory virus activity and environmental factors with the incidence of invasive pneumococcal disease. J Infect. (2009) 58(1):37–46. 10.1016/j.jinf.2008.10.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2008.10.011</ArticleId><ArticleId IdType="pubmed">19042025</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolter N, Tempia S, Cohen C, Madhi SA, Venter M, Moyes J, et al. High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia. J Infect Dis. (2014) 210(10):1649–57. 10.1093/infdis/jiu326</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu326</ArticleId><ArticleId IdType="pubmed">24907383</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Brien KL, Walters MI, Sellman J, Quinlisk P, Regnery H, Schwartz B, et al. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis. (2000) 30(5):784–9. 10.1086/313772</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/313772</ArticleId><ArticleId IdType="pubmed">10816149</ArticleId></ArticleIdList></Reference><Reference><Citation>Stensballe LG, Hjuler T, Andersen A, Kaltoft M, Ravn H, Aaby P, et al. Hospitalization for respiratory syncytial virus infection and invasive pneumococcal disease in Danish children aged &lt;2 years: a population-based cohort study. Clin Infect Dis. (2008) 46(8):1165–71. 10.1086/529438</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/529438</ArticleId><ArticleId IdType="pubmed">18444851</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberger DM, Grant LR, Steiner CA, Weatherholtz R, Santosham M, Viboud C, et al. Seasonal drivers of pneumococcal disease incidence: impact of bacterial carriage and viral activity. Clin Infect Dis. (2014) 58(2):188–94. 10.1093/cid/cit721</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cit721</ArticleId><ArticleId IdType="pmc">PMC3871795</ArticleId><ArticleId IdType="pubmed">24190895</ArticleId></ArticleIdList></Reference><Reference><Citation>Peltola V, Heikkinen T, Ruuskanen O, Jartti T, Hovi T, Kilpi T, et al. Temporal association between rhinovirus circulation in the community and invasive pneumococcal disease in children. Pediatr Infect Dis J. (2011) 30(6):456–61. 10.1097/INF.0b013e318208ee82</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0b013e318208ee82</ArticleId><ArticleId IdType="pubmed">21200362</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberger DM, Klugman KP, Steiner CA, Simonsen L, Viboud C. Association between respiratory syncytial virus activity and pneumococcal disease in infants: a time series analysis of US hospitalization data. PLoS Med. (2015) 12(1):e1001776. 10.1371/journal.pmed.1001776</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001776</ArticleId><ArticleId IdType="pmc">PMC4285401</ArticleId><ArticleId IdType="pubmed">25562317</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan RR, Howard LM, Griffin MR, Edwards KM, Zhu Y, Williams JV, et al. Nasopharyngeal pneumococcal density and evolution of acute respiratory illnesses in young children, Peru, 2009–2011. Emerg Infect Dis. (2016) 22(11):1996–9. 10.3201/eid2211.160902</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2211.160902</ArticleId><ArticleId IdType="pmc">PMC5088003</ArticleId><ArticleId IdType="pubmed">27767919</ArticleId></ArticleIdList></Reference><Reference><Citation>Vu HTT, Yoshida LM, Suzuki M, Nguyen HAT, Nguyen CDL, Nguyen ATT, et al. Association between nasopharyngeal load of streptococcus pneumoniae, viral coinfection, and radiologically confirmed pneumonia in Vietnamese children. Pediatr Infect Dis J. (2011) 30(1):11–8. 10.1097/INF.0b013e3181f111a2</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0b013e3181f111a2</ArticleId><ArticleId IdType="pubmed">20686433</ArticleId></ArticleIdList></Reference><Reference><Citation>Morpeth SC, Munywoki P, Hammitt LL, Bett A, Bottomley C, Onyango CO, et al. Impact of viral upper respiratory tract infection on the concentration of nasopharyngeal pneumococcal carriage among Kenyan children. Sci Rep. (2018) 8:11030. 10.1038/s41598-018-29119-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-29119-w</ArticleId><ArticleId IdType="pmc">PMC6056465</ArticleId><ArticleId IdType="pubmed">30038420</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMuri GP, Gern JE, Eickhoff JC, Lynch SV, Wald ER. Dynamics of bacterial colonization with streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis during symptomatic and asymptomatic viral upper respiratory tract infection. Clin Infect Dis. (2018) 66(7):1045–53. 10.1093/cid/cix941</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix941</ArticleId><ArticleId IdType="pmc">PMC6019034</ArticleId><ArticleId IdType="pubmed">29121208</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard LM, Zhu Y, Griffin MR, Edwards KM, Williams JV, Gil AI, et al. Nasopharyngeal pneumococcal density during asymptomatic respiratory virus infection and risk for subsequent acute respiratory illness. Emerg Infect Dis. (2019) 25(11):2040–7. 10.3201/eid2511.190157</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2511.190157</ArticleId><ArticleId IdType="pmc">PMC6810199</ArticleId><ArticleId IdType="pubmed">31625844</ArticleId></ArticleIdList></Reference><Reference><Citation>Thors V, Christensen H, Morales-Aza B, Oliver E, Sikora P, Vipond I, et al. High-density bacterial nasal carriage in children is transient and associated with respiratory viral infections—implications for transmission dynamics. Pediatr Infect Dis J. (2019) 38(5):533–8. 10.1097/INF.0000000000002256</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002256</ArticleId><ArticleId IdType="pubmed">30985547</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu HY, Chu HY, Boeckh M, Boeckh M, Englund JA, Englund JA, et al. LB21. The seattle flu study: a community-based study of influenza. Open Forum Infect Dis. (2019) 6(Suppl 2):S1002. 10.1093/ofid/ofz415.2504</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofz415.2504</ArticleId></ArticleIdList></Reference><Reference><Citation>Emanuels A, Heimonen J, O’Hanlon J, Kim AE, Wilcox N, McCulloch DJ, et al. Remote household observation for noninfluenza respiratory viral illness. Clin Infect Dis. (2020) 73(11):e4411–8. 10.1093/cid/ciaa1719</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1719</ArticleId><ArticleId IdType="pmc">PMC7717193</ArticleId><ArticleId IdType="pubmed">33197930</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. (2019) 95:103208. 10.1016/j.jbi.2019.103208</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103208</ArticleId><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. (2009) 42(2):377–81. 10.1016/j.jbi.2008.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim AE, Brandstetter E, Wilcox N, Heimonen J, Graham C, Han PD, et al. Evaluating specimen quality and results from a community-wide, home-based respiratory surveillance study. J Clin Microbiol. (2021) 59(5):e02934–20. 10.1128/JCM.02934-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02934-20</ArticleId><ArticleId IdType="pmc">PMC8091861</ArticleId><ArticleId IdType="pubmed">33563599</ArticleId></ArticleIdList></Reference><Reference><Citation>A complete workflow solution for detecting respiratory tract microbiota using OpenArray technology.</Citation></Reference><Reference><Citation>Thermo Fisher Scientific Inc. Crt, a relative threshold method for qPCR data analysis on the QuantStudio 12 K Flex system with OpenArray technology (2016).</Citation></Reference><Reference><Citation>Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. (1986) 73(1):13–22. 10.1093/biomet/73.1.13</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biomet/73.1.13</ArticleId></ArticleIdList></Reference><Reference><Citation>Satzke C, Turner P, Virolainen-Julkunen A, Adrian PV, Antonio M, Hare KM, et al. Standard method for detecting upper respiratory carriage of streptococcus pneumoniae: updated recommendations from the world health organization pneumococcal carriage working group. Vaccine. (2013) 32(1):165–79. 10.1016/j.vaccine.2013.08.062</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.08.062</ArticleId><ArticleId IdType="pubmed">24331112</ArticleId></ArticleIdList></Reference><Reference><Citation>Roca A, Bottomley C, Hill PC, Bojang A, Egere U, Antonio M, et al. Effect of age and vaccination with a pneumococcal conjugate vaccine on the density of pneumococcal nasopharyngeal carriage. Clin Infect Dis. (2012) 55(6):816–24. 10.1093/cid/cis554</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cis554</ArticleId><ArticleId IdType="pmc">PMC3423933</ArticleId><ArticleId IdType="pubmed">22700830</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilishvili T, Bennett NM. Pneumococcal disease prevention among adults: strategies for the use of pneumococcal vaccines. Vaccine. (2015) 33:D60–5. 10.1016/j.vaccine.2015.05.102</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.05.102</ArticleId><ArticleId IdType="pubmed">26116257</ArticleId></ArticleIdList></Reference><Reference><Citation>Danino D, Ben-Shimol S, Van Der Beek BA, Givon-Lavi N, Avni YS, Greenberg D, et al. Decline in pneumococcal disease in young children during the COVID-19 pandemic in Israel associated with suppression of seasonal respiratory viruses, despite persistent pneumococcal carriage: a prospective cohort study. Clin Infect Dis. (2021) 75(1):e1154–e1164. 10.1093/cid/ciab1014</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab1014</ArticleId><ArticleId IdType="pmc">PMC8754767</ArticleId><ArticleId IdType="pubmed">34904635</ArticleId></ArticleIdList></Reference><Reference><Citation>Rybak A, Levy C, Angoulvant F, Auvrignon A, Gembara P, Danis K, et al. Association of nonpharmaceutical interventions during the COVID-19 pandemic with invasive pneumococcal disease, pneumococcal carriage, and respiratory viral infections among children in France. JAMA Netw Open. (2022) 5(6):e2218959. 10.1001/jamanetworkopen.2022.18959</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.18959</ArticleId><ArticleId IdType="pmc">PMC9240903</ArticleId><ArticleId IdType="pubmed">35763298</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen SJ, Winn AK, Budd AP, Prill MM, Steel J, Midgley CM, et al. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic — United States, 2020–2021. MMWR Morb Mortal Wkly Rep. (2021) 70:1013–9. 10.15585/mmwr.mm7029a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7029a1</ArticleId><ArticleId IdType="pmc">PMC8297694</ArticleId><ArticleId IdType="pubmed">34292924</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddadin Z, Schuster JE, Spieker AJ, Rahman H, Blozinski A, Stewart L, et al. Acute respiratory illnesses in children in the SARS-CoV-2 pandemic: prospective multicenter study. Pediatrics. (2021) 148(2):e2021051462. 10.1542/peds.2021-051462</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2021-051462</ArticleId><ArticleId IdType="pmc">PMC8338906</ArticleId><ArticleId IdType="pubmed">33986150</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang QS, Wood T, Jelley L, Jennings T, Jefferies S, Daniells K, et al. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand. Nat Commun. (2021) 12(1):1001. 10.1038/s41467-021-21157-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21157-9</ArticleId><ArticleId IdType="pmc">PMC7881137</ArticleId><ArticleId IdType="pubmed">33579926</ArticleId></ArticleIdList></Reference><Reference><Citation>Foley DA, Yeoh DK, Minney-Smith CA, Martin AC, Mace AO, Sikazwe CT, et al. The interseasonal resurgence of respiratory syncytial virus in Australian children following the reduction of coronavirus disease 2019–related public health measures. Clin Infect Dis. (2021) 73(9):e2829–30. 10.1093/cid/ciaa1906</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1906</ArticleId><ArticleId IdType="pmc">PMC7929151</ArticleId><ArticleId IdType="pubmed">33594407</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol. (2022) 21(3):195–201. 10.1038/s41579-022-00807-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00807-9</ArticleId><ArticleId IdType="pmc">PMC9574826</ArticleId><ArticleId IdType="pubmed">36253478</ArticleId></ArticleIdList></Reference><Reference><Citation>Grijalva CG, Griffin MR, Edwards KM, Johnson M, Gil AI, Verastegui H, et al. Concordance between RT-PCR-based detection of respiratory viruses from nasal swabs collected for viral testing and nasopharyngeal swabs collected for bacterial testing. J Clin Virol. (2014) 60(3):309–12. 10.1016/j.jcv.2014.04.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2014.04.011</ArticleId><ArticleId IdType="pmc">PMC4055503</ArticleId><ArticleId IdType="pubmed">24875136</ArticleId></ArticleIdList></Reference><Reference><Citation>Varon E, Cohen R, Béchet S, Doit C, Levy C. Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children. Vaccine. (2015) 33(46):6178–85. 10.1016/j.vaccine.2015.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.10.015</ArticleId><ArticleId IdType="pubmed">26476365</ArticleId></ArticleIdList></Reference><Reference><Citation>Brueggemann AB, Peto TEA, Crook DW, Butler JC, Kristinsson KG, Spratt BG. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis. (2004) 190(7):1203–11. 10.1086/423820</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/423820</ArticleId><ArticleId IdType="pubmed">15346329</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanage WP, Kaijalainen TH, Syrjänen RK, Auranen K, Leinonen M, Mäkelä PH, et al. Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland. Infect Immun. (2005) 73(1):431–5. 10.1128/IAI.73.1.431-435.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.73.1.431-435.2005</ArticleId><ArticleId IdType="pmc">PMC538975</ArticleId><ArticleId IdType="pubmed">15618181</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R. Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis. Pediatr Infect Dis J. (2006) 25(7):602–7. 10.1097/01.inf.0000220231.79968.f6</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.inf.0000220231.79968.f6</ArticleId><ArticleId IdType="pubmed">16804429</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen R, Levy C, Ouldali N, Goldrey M, Béchet S, Bonacorsi S, et al. Invasive disease potential of pneumococcal serotypes in children after PCV13 implementation. Clin Infect Dis. (2021) 72(8):1453–6. 10.1093/cid/ciaa917</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa917</ArticleId><ArticleId IdType="pubmed">32804200</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenberg D, Givon-Lavi N, Faingelernt Y, Ben-Shimol S, Avni YS, Bar-Ziv J, et al. Nasopharyngeal pneumococcal carriage during childhood community-acquired alveolar pneumonia: relationship between specific serotypes and coinfecting viruses. J Infect Dis. (2017) 215(7):1111–6. 10.1093/infdis/jiw613</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiw613</ArticleId><ArticleId IdType="pubmed">28011920</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>